-
www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/ambulatory-care/skin-soft-tissue-discussion-guide.docx
September 01, 2022 - What antibiotics and antibiotic dosages should the practice recommend for treatment of nonpurulent and … What recommendations will the practice make about non-antibiotic therapies for cellulitis?
3.
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/primary-care-based-efforts.pdf
March 01, 2019 - • The intervention group received calls from
pharmacists who conducted a medication
therapy assessment … • At these appointments, pharmacists
identified drug therapy problems and
worked to resolve these … 4.6 encounters per patient over
11 months
• Pharmacists identified an
average of 10.4 drug therapy … They identified
drug therapy problems, including inappropriate medications, adverse reactions, difficulty … adhering to treatments, and financial barriers, and worked to resolve these problems with
the retail
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/PrimaryCareEffortsToReduceReadmissions-envscan.pdf
March 01, 2020 - • The intervention group received calls from
pharmacists who conducted a medication
therapy assessment … • At these appointments, pharmacists
identified drug therapy problems and
worked to resolve these … 4.6 encounters per patient over
11 months
• Pharmacists identified an
average of 10.4 drug therapy … They identified
drug therapy problems, including inappropriate medications, adverse reactions, difficulty … adhering to treatments, and financial barriers, and worked to resolve these problems with
the retail
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/outcomes/chipra-146-section-5.pdf
January 01, 2014 - assessed knowledge of adult
survivors of childhood cancer about
their primary cancer diagnosis and
therapies … Childhood
cancer survivors' knowledge
about their past diagnosis and
treatment: Childhood Cancer … psychometric properties of a survey
tool designed to evaluate children's level
of independence in their CF treatment … ,
as this may have a direct effect on their
involvement in treatment and adherence. … parents were equally likely to answer
questions correctly regarding disease
characteristics and treatment
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2018qdr-datasources.pdf
October 01, 2019 - quality of health services, medical practice
patterns, access to healthcare programs, and outcomes of treatments … The large sample
size in the NIS enables analyses of rare conditions, uncommon treatments, and special … To evaluate the
outcomes of TB therapy, RVCT Follow up Report-2 was added to collect information on … of directly observed therapy, and results of drug susceptibility testing for the final M. … and where, and reason therapy was extended for more than 12
months.
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-fullreport.pdf
February 01, 2018 - Patient or surrogate decision-maker declined or is unwilling to consent to therapies.
1.I. … Patient or surrogate decision-maker declined or is unwilling to consent to therapies.
1.K. … The current management strategy for treatment of sepsis is goal-directed therapy, with institution
of … antimicrobial and hemodynamic (i.e., relating to the forces driving blood flow
throughout the body) treatments … and blood pressure; and maintain or restore threshold heart rate (Brierley, et al., 2009).
11
Therapeutic
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2019qdr-datasources.pdf
December 01, 2020 - quality of health services, medical practice
patterns, access to healthcare programs, and outcomes of treatments … The large sample size in the NIS enables analyses of
rare conditions, uncommon treatments, and special … To evaluate the
outcomes of TB therapy, RVCT Follow up Report-2 was added. … This report collects information
on the reason and date therapy was stopped, type of healthcare provider … and where, and
• Reason therapy was extended for more than 12 months.
-
www.ahrq.gov/sites/default/files/2024-01/higginson-report.pdf
January 01, 2024 - Borrowing medications from one resident’s supply to sustain treatment for
another resident when the … receives a drug prescribed that is not clinically indicated (contraindicated, known allergy,
duplicate therapy … Error Category
Wrong
drug
7.3 5.0 4.1 6/4,481 or .001
Known
allergy
11.7 12.9 14.4
Duplicate
therapy … Orders
Rate of Errors per 1000
Doses
Wrong
drug
0.6 1.2 1.3
Known
allergy
1.5 0.9
Duplicate
therapy
-
www.ahrq.gov/sites/default/files/2024-02/kleinman-report.pdf
January 01, 2024 - Hospitalization for a Mental Illness, (6) Initiation and
Engagement of Alcohol and Other Drug Dependence Treatment … a clinical rationale to allow for medications to be
titrated up or down when used concurrently in therapy … the
frequency or severity of the side effects but generally would not require a major alteration in therapy … interaction may result in an exacerbation of the patient's condition
and/or require an alteration in therapy … Therefore, one interpretation of these data is that in vivo therapeutic trials are a common
attempt
-
www.ahrq.gov/sites/default/files/2024-04/maraganore-report.pdf
January 01, 2024 - patient was
eligible for enrollment in a comparative effectiveness pragmatic trial that assigned a treatment … survival free at 12 months of discontinuation
of the assigned drug or the prescription of an adjunctive therapy … Some initial programming errors in treatment
assignments were resolved. … as captured by the EMR (Failure = the assigned treatment failed, Success = the assigned treatment succeed … ,
Pending = the assigned treatment outcome is pending).
-
www.ahrq.gov/sites/default/files/2024-07/earp-report.pdf
January 01, 2024 - This includes the sharing of decision
making, risks, cost effectiveness, treatment regimens, goals and … of health disciplines,
including health policy and administration, pharmacy, nursing, occupational therapy
-
www.ahrq.gov/sites/default/files/2024-04/etchegaray-report.pdf
January 01, 2024 - o Debriefings need to be done by trained professionals, because they can turn
into therapy sessions
-
www.ahrq.gov/sites/default/files/2024-07/nuckols-report.pdf
January 01, 2024 - Affordable Care Act;
poor health literacy, which reduces patients’ abilities to benefit from effective therapy … ; and diseases,
such as cancer, for which more effective treatments would be highly valued.
-
www.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/hospital/workplace-safety/workplace_safety_pilotstudyreport.pdf
November 01, 2021 - Clinical Services
Pathology, Lab 233 3%
Pharmacy 264 4%
Radiology, Imaging 240 3%
Respiratory Therapy
-
www.ahrq.gov/sites/default/files/wysiwyg/action-alliance/public-action-alliance-slides-040323_LOCKED.pdf
May 25, 2023 - Medical Group
Locations
73
Ambulatory
Surgery
Centers
185
Imaging
Locations
302
Physical
Therapy
-
www.ahrq.gov/sites/default/files/wysiwyg/action-alliance/addressing-workforce-safety-chat-062723.pdf
June 27, 2023 - a CARE Team as peer support for WPV events
from Bridget Evans to everyone: 2:46 PM
That's a therapy
-
www.ahrq.gov/sites/default/files/wysiwyg/sops/quality-patient-safety/patientsafetyculture/healthitpatientsafetyitemset-hospitals-pilottestreport.pdf
March 01, 2018 - Services Number Percent
Pathology, Lab 241 3%
Pharmacy 216 2%
Radiology, Imaging 422 5%
Respiratory Therapy
-
www.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/hospital/hsops2-pilot-results-parti.pdf
September 01, 2019 - 18 <1%
Pre Op, Operating Room/Suite, PACU/Post Op, Peri Op 239 6%
Clinical Services
Respiratory Therapy
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Cook.pdf
January 01, 2004 - However, when the case
studies contained errors associated with diagnosis and/or treatment, included … in
the Institute of Medicine’s definitions of errors (delays in treatment; use of
outmoded treatments … Nurses who responded to the case studies were also hesitant to designate
treatment and diagnostic issues … For
example, participating pharmacists who encountered problems in the management
of warfarin therapies … Although health care research has traditionally relied on experimental,
control/treatment group design
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol2/Advances-Shah_99.pdf
March 23, 2008 - other than substandard care included: (a) “Doing harm
without consideration of alternative medical therapies … “Doing harm without
consideration of alternative
medical therapies, or inattention
to procedure/clinical … “Not offering proper use of treatment
when necessary due to absence, or
failed application.” … : Patient has severe asthma
Standard of care: Provision of steroids
“Not entertaining a possible treatment … Patient has severe asthma
Standard of care: Provision of steroids
“Not entertaining a
possible treatment